Cargando…

AKT Kinase Pathway: A Leading Target in Cancer Research

AKT1, a serine/threonine-protein kinase also known as AKT kinase, is involved in the regulation of various signalling downstream pathways including metabolism, cell proliferation, survival, growth, and angiogenesis. The AKT kinases pathway stands among the most important components of cell prolifera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Ambuj, Rajendran, Vidya, Sethumadhavan, Rao, Purohit, Rituraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845396/ https://www.ncbi.nlm.nih.gov/pubmed/24327805 http://dx.doi.org/10.1155/2013/756134

Ejemplares similares

In silico prediction of a disease-associated STIL mutant and its affect on the recruitment of centromere protein J (CENPJ)
por: Kumar, Ambuj, et al.
Publicado: (2012)

Molecular Dynamic Simulation Reveals Damaging Impact of RAC1 F28L Mutation in the Switch I Region
por: Kumar, Ambuj, et al.
Publicado: (2013)

Cancer Associated E17K Mutation Causes Rapid Conformational Drift in AKT1 Pleckstrin Homology (PH) Domain
por: Kumar, Ambuj, et al.
Publicado: (2013)

Evolutionary Reconstruction and Population Genetics Analysis of Aurora Kinases
por: Kamaraj, Balu, et al.
Publicado: (2013)

Use of Long Term Molecular Dynamics Simulation in Predicting Cancer Associated SNPs
por: Kumar, Ambuj, et al.
Publicado: (2014)

Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2
por: Bhardwaj, Vijay Kumar, et al.
Publicado: (2021)

An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2
por: Sharma, Jatin, et al.
Publicado: (2021)

Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
por: Al Amin, Md., et al.
Publicado: (2023)

Structural Perturbations due to Mutation (H1047R) in Phosphoinositide-3-kinase (PI3Kα) and Its Involvement in Oncogenesis: An in Silico Insight
por: Sharma, Jatin, et al.
Publicado: (2019)

Mutational Analysis of Oculocutaneous Albinism: A Compact Review
por: Kamaraj, Balu, et al.
Publicado: (2014)

Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——AKT/m-TOR Pathway and Resistance to Cancer Therapy
por: SPIRINA, Liudmila V, et al.
Publicado: (2018)

Computer-Aided Identification of Kinase-Targeted Small Molecules for Cancer: A Review on AKT Protein
por: Primavera, Erika, et al.
Publicado: (2023)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

Role of Akt/Protein Kinase B in Cancer Metastasis
por: Islam, Mohammad, et al.
Publicado: (2023)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
por: Aziz, Aziz Ur Rehman, et al.
Publicado: (2018)

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
por: Ghareghomi, Somayyeh, et al.
Publicado: (2023)

The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?
por: Omarjee, Loukman, et al.
Publicado: (2017)

Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
por: Liu, Wei-Lin, et al.
Publicado: (2014)

Hesperidin Interacts With CREB-BDNF Signaling Pathway to Suppress Pentylenetetrazole-Induced Convulsions in Zebrafish
por: Sharma, Pallavi, et al.
Publicado: (2021)

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
por: Glaviano, Antonino, et al.
Publicado: (2023)

Potential of turmeric-derived compounds against RNA‐dependent RNA polymerase of SARS‐CoV‐2: An in-silico approach
por: Singh, Rahul, et al.
Publicado: (2021)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
por: Li, Huayi, et al.
Publicado: (2021)

Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products
por: Shiau, Jun-Ping, et al.
Publicado: (2023)

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
por: Wanigasooriya, Kasun, et al.
Publicado: (2020)

In Silico Screening and Molecular Dynamics Simulation of Disease-Associated nsSNP in TYRP1 Gene and Its Structural Consequences in OCA3
por: Kamaraj, Balu, et al.
Publicado: (2013)

Targeting Akt in cancer for precision therapy
por: Hua, Hui, et al.
Publicado: (2021)

SRC kinase-mediated signaling pathways and targeted therapies in breast cancer
por: Luo, Juan, et al.
Publicado: (2022)

The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology
por: Martelli, Alberto M., et al.
Publicado: (2010)

PIM Kinase as an Executional Target in Cancer
por: Zhang, Xinning, et al.
Publicado: (2018)

Therapeutic Implications of Targeting AKT Signaling in Melanoma
por: Madhunapantula, SubbaRao V., et al.
Publicado: (2011)

Amplification and Demultiplexing in Insulin-regulated Akt Protein Kinase Pathway in Adipocytes
por: Tan, Shi-Xiong, et al.
Publicado: (2012)

Single Nucleotide Polymorphisms in MicroRNA Binding Sites: Implications in Colorectal Cancer
por: Bhaumik, Panchalee, et al.
Publicado: (2014)

New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response
por: Szymonowicz, Klaudia, et al.
Publicado: (2018)

Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers
por: Goda, Jayant S., et al.
Publicado: (2016)

The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway
por: Gupta, Kartikey Kumar, et al.
Publicado: (2022)

A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2
por: Singh, Rahul, et al.
Publicado: (2021)

Molecular target: pan-AKT in gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2020)

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
por: Li, Qingfang, et al.
Publicado: (2022)

Using Existing Drugs as Leads for Broad Spectrum Anthelmintics Targeting Protein Kinases
por: Taylor, Christina M., et al.
Publicado: (2013)

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
por: Bhardwaj, Vijay Kumar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_18dbhlu4ohb6ui99n2vupjepu3